Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Yachmetz Philip K
Relationship:   Co-President and CBO
City:   Wyckoff
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   98,241    

Indirect Shares

   200      
Direct Value   $31,554    

Indirect Value

   $820      
Total Shares   98,441      
Total Value   $32,374      


Progenics Pharmaceuticals Inc $31,554 Savient Pharmaceuticals Inc $0 Progenics Pharmaceuticals Inc $31,554 Savient Pharmaceuticals Inc $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Progenics Pharmaceuticals Inc PGNX VP, General Counsel 2004-05-03 7,696 2004-05-03 200    Premium*  
            Savient Pharmaceuticals Inc SVNTQ Co-President and CBO 2013-10-15 90,545 2004-06-04 0    Premium*  
* Premium Members only  

Records found :    53         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2005-04-13 4 A $0.00 $0 D/D 32,050 42,050 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2006-02-15 4 A $0.00 $0 D/D 20,000 72,050 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2006-12-08 4 A $0.00 $0 D/D 45,000 112,058 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2007-02-15 4 A $0.00 $0 D/D 20,790 129,797 0 -
SVNTQ Savient Pharmaceuticals I... Co-President and CBO   •       –      –    2013-10-15 4 S $0.09 $20,835 D/D (213,156) 90,545 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2013-02-04 4 AS $1.01 $30,837 D/D (30,500) 303,701 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2013-01-14 4 AS $1.14 $1,463 D/D (1,283) 334,201 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2012-02-14 4 AS $2.02 $7,151 D/D (3,540) 235,484 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2012-02-01 4 A $2.26 $113,000 D/D 50,000 239,024 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-02 4 OE $2.42 $12,100 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-03 4 OE $2.42 $13,450 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-07 4 OE $2.42 $13,450 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-08 4 OE $2.42 $12,100 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-04 4 OE $2.78 $13,900 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2004-06-04 4 A $2.89 $29,525 D/D 10,000 10,000 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2005-05-18 4 B $3.08 $31,840 D/D 10,000 52,050 2.74 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2011-09-16 4 B $4.13 $28,910 D/D 7,000 189,024 2.74 -
SVNTQ Savient Pharmaceuticals I... SVP - General Counsel   •       –      –    2008-12-08 4 A $4.53 $67,950 D/D 15,000 173,091 0 -
SVNTQ Savient Pharmaceuticals I... SVP - General Counsel   •       –      –    2008-12-09 4 AS $4.86 $31,104 D/D (6,400) 166,691 0 -
SVNTQ Savient Pharmaceuticals I... EVP - Chief Business Officer   •       –      –    2008-11-04 4 D $5.17 $52,837 D/D (10,220) 158,091 0 -
SVNTQ Savient Pharmaceuticals I... EVP - Chief Business Officer   •       –      –    2008-11-04 4 A $5.17 $116,325 D/D 22,500 168,311 0 -
SVNTQ Savient Pharmaceuticals I... SVP - General Counsel   •       –      –    2009-02-17 4 AS $5.73 $33,635 D/D (5,868) 185,823 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2006-04-12 4 AS $5.87 $29,297 D/D (4,992) 67,058 -
SVNTQ Savient Pharmaceuticals I... SVP - General Counsel   •       –      –    2009-02-13 4 A $5.94 $148,500 D/D 25,000 191,691 0 -
SVNTQ Savient Pharmaceuticals I... SVP - General Counsel   •       –      –    2009-02-13 4/A A $5.94 $148,500 D/D 25,000 191,691 0 -
  53  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us